Summary
Updated Aug 31, 2026
Helen M. Thackray is Chief R&D Officer of BIOCRYST PHARMACEUTICALS INC (BCRX). 2 SEC Form 4 filings on record, most recently on 23 December 2024.
Recent Transactions
3Every recent SEC Form 4 transaction Helen M. Thackray has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Helen M. Thackray go back to 2024: 2 primary Form 4 filings, an average of 0.7 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Helen M. Thackray files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alane P. Barnes - $3.46M of BCRX open-market activity in the last 12 months
- Theresa Heggie - $505K of BCRX open-market activity in the last 12 months
- Amy E. McKee - $100K of BCRX open-market activity in the last 12 months
- Machelle Sanders - $69K of BCRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Helen M. Thackray?
Helen M. Thackray is a corporate insider, tracked as Chief R&D Officer of BIOCRYST PHARMACEUTICALS INC (BCRX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Helen M. Thackray last file a Form 4?
The most recent primary Form 4 on record is dated 23 December 2024, one of 2 filings going back to 2024.
Where can I see all of Helen M. Thackray's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Helen M. Thackray and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial